Web Analytics
KRRO (NASDAQ) 株価分析 | KORRO BIO, INC. – Deepscope
MARKET

Select Market Data Region

KRRO 株価分析 — Korro Bio, Inc. (Healthcare >> Biotechnology)

KRRO に関するよくある質問

KRROのROE(自己資本利益率)は?

Korro Bio, Inc.のROEは-94.87%です。

KRROの配当利回りは?

Korro Bio, Inc.の配当利回りは0.00%です。

KRROの品質スコア(Quality Score)は?

当社のAIはKRROの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

KRROは今が買い時ですか?

当社AIのタイミングスコアは100点中26点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

KRROはどのセクターに属しますか?

Korro Bio, Inc.はHealthcare >> Biotechnologyセクターに分類されます(NASDAQ市場)

Stock Check   *Daily update data at 8:30 AM*
(Price: 2026-07-31 | FS: 2026-03-31)

KRRO AI Analysis Summary

Our AI summary for KRRO: Korro Bio, Inc. (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -94.87%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

KRRO

Korro Bio, Inc.
USD 10.37
-0.08 (-0.77%) Day Change
0.02
D/E
-94.9%
ROE
-61.8%
ROA
0.00%
Div Yield
USD 10.37
Price
-0.08 (-0.77%)
Day Change
NEWS SCORE: 98

KRRO, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...

31

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Momentum indicators aligned on the daily timeframe
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析 47%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 98
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 10.37
  PBV / Sector
1.26 / 5.20
GOOD
  Earning Per Share -7.81
  PE / Sector
N/A / 19.97
  PEG or PE/Growth / Sector
N/A / 1.22
  Average 1M Daily Value
2.37 M
GREAT
  Average 1W Daily Value
1.38 M
GREAT
Timing Factors 42%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Financial Health 45%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
ポイントになる統計 52%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
-2,954.14 / 98.71
  NPM Average (%) / Sector
-2,822.99 / -1,721.76
  NPM Change Average (%) / Sector
N/A / 5,211.62
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-61.81 / 27.02
  ROA Average (%) / Sector
-63.48 / -368.17
  ROA Change Average (%) / Sector
21.72 / 5,404.12
GREAT
  ROE (%) / Sector
-94.87 / 3.47
  ROE Average (%) / Sector
-72.82 / 6.51
  ROE Change Average (%) / Sector
26.67 / 2,128.13
GREAT
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
配当 4%
X
  Dividend (%) / Sector
N/A / 0.04
  Dividend Average (%) / Sector
N/A / 17.04
  Dividend Change Average (%) / Sector
N/A / -1.75
登録情報
X
  Analyze Date 2026-08-01 08:00:05
  Symbol KRRO
  Name KORRO BIO, INC.
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 14.42 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 150.72 / 9,903.94
ニュース
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 60 First Street, Cambridge, MA, United States, 02141

Phone: 617 468 1999

Website: https://www.korrobio.com

Sector: Healthcare >> Biotechnology

Description: Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Analyst Ratings & Target Price

3 Months Ago
1 Month Ago
Current
Strong Buy
6
6
6
Buy
4
4
4
Hold
0
0
0
Sell
0
0
0
Strong Sell
0
0
0
Consensus
Strong Buy 4.60
Strong Buy 4.60
Strong Buy 4.60
Target Price
USD 20.00
USD 20.00
USD 20.00

Per-Share Earnings, Estimates vs Actuals

Actual
Analyst Range
Estimate

ME vs SECTOR Healthcare >> Biotechnology

KRRO (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

同業種の銘柄

Healthcare › Biotechnology

同じ基準で分析・時価総額順

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
KRRO
KRRO
USD 10.37 (-0.77%)
+ Watch + Port Chart